Cadrenal Therapeutics
CVKD
#9731
Rank
A$50.94 M
Marketcap
$26.26
Share price
-1.18%
Change (1 day)
165.02%
Change (1 year)

EPS for Cadrenal Therapeutics (CVKD)

EPS in 2024 (TTM): -$10.39

According to Cadrenal Therapeutics's latest financial reports the company's current EPS (TTM) is -$10.85. In 2023 the company made an earnings per share (EPS) of -$14.52.

EPS history for Cadrenal Therapeutics from 2023 to 2024

Annual EPS

Year EPS Change
2024 (TTM)-$10.39-28.47%
2023-$14.52